MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

SELLAS

Search medical newsFind research, conditions and clinical updates
  • Home
  • SELLAS
3d blood syringe on test tube with red tumor. Cancer treatment, oncology research, medical diagnostics, chemotherapy, biomedical analysis concept. Low poly digital futuristic style, wireframe. Vector.
Posted inClinical Updates Hematology-Oncology

SELLAS Life Sciences’ Cancer Vaccine Galinpepimut-S Meets Primary Endpoint in Phase 3 AML Trial, Cutting Risk of Death by 41%

Posted by By Zhang Paul 11/17/2026
iStock, Alena Butusava NEW YORK — November 17, 2026 — SELLAS Life Sciences Group, Inc.…
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Concentrating Weekly Exercise Into the Weekend Cuts Cardiovascular Risk by 25% in Patients With Hypertension
  • SELLAS Life Sciences’ Cancer Vaccine Galinpepimut-S Meets Primary Endpoint in Phase 3 AML Trial, Cutting Risk of Death by 41%
  • Enhancing Patient-Centered Communication Through Understanding Racial-Ethnic-Cultural Belonging in US Adults
  • Modulating Neutrophil Adhesion: The Role of FERMT3 Alternative Splicing in Stress Myelopoiesis
  • Clinician-Guided Digital CBT-I Significantly Enhances Sleep Quality and Reduces Apnea in COMISA Patients: Insights from a Double-Blind RCT
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top